Cargando…
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) Cohort Study
IMPORTANCE: Racial and ethnic groups with higher rates of clinical Alzheimer disease (AD) are underrepresented in studies of AD biomarkers, including amyloid positron emission tomography (PET). OBJECTIVE: To compare amyloid PET positivity among a diverse cohort of individuals with mild cognitive imp...
Autores principales: | Wilkins, Consuelo H., Windon, Charles C., Dilworth-Anderson, Peggye, Romanoff, Justin, Gatsonis, Constantine, Hanna, Lucy, Apgar, Charles, Gareen, Ilana F., Hill, Carl V., Hillner, Bruce E., March, Andrew, Siegel, Barry A., Whitmer, Rachel A., Carrillo, Maria C., Rabinovici, Gil D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531087/ https://www.ncbi.nlm.nih.gov/pubmed/36190710 http://dx.doi.org/10.1001/jamaneurol.2022.3157 |
Ejemplares similares
-
Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
por: Rabinovici, G. D., et al.
Publicado: (2009) -
Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment
por: Hu, Yan, et al.
Publicado: (2022) -
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
por: Laforce, Robert, et al.
Publicado: (2011) -
Beta-amyloid imaging in dementia
por: Chun, Kyung Ah
Publicado: (2018) -
Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease
por: Withington, Charles G., et al.
Publicado: (2022)